VIVIDION THERAPEUTICS
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target discovery. Making accessible the broad set of proteins expressed in human cells, the company’s platform was spun out of the labs of Vividion’s scientific founders, a team of experts in chemical biology and synthetic chemistry from The Scripps Research Institute in La Jolla, CA. Vividion is committed to advancing and applying its pioneering synthetic and proteomic chemistry platforms to create therapeutics that will make a transformative difference in patients.
VIVIDION THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2013-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.vividion.com
Total Employee:
101+
Status:
Active
Contact:
(609)924-6452
Total Funding:
371.5 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Google Google Cloud Microsoft Akamai Hosted
Similar Organizations
Aurinia Pharmaceuticals
Aurinia develops and commercializes therapies to treat targeted patient populations suffering from serious auto-immune diseases.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Evvy
Evvy is for people with vaginas who want to be empowered with information about their microbiome.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
PresenceLearning
PresenceLearning makes live, online special education related services available to K-12 students.
Relay Therapeutics
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
XOMA
XOMA is at the forefront of antibody discovery and development, one of the most powerful and transformative fields of drug innovation
Current Advisors List
Board_member
Board_member
Board_member
Board_member
Board_member
Board_member
Current Employees Featured
Shawn Rose Chief Development Officer (CDO), Immunology @ Vividion Therapeutics
Chief Development Officer (CDO), Immunology
2023-08-01
Diego Miralles CEO @ Vividion Therapeutics
CEO
2017-09-01
Benjamin Cravatt Founder @ Vividion Therapeutics
Founder
Jean Bemis Senior Vice President of Operations and Alliances @ Vividion Therapeutics
Senior Vice President of Operations and Alliances
2022-01-01
Jin-Quan Yu Founder @ Vividion Therapeutics
Founder
Patricia Allen Chief Financial Officer @ Vividion Therapeutics
Chief Financial Officer
2021-03-01
Jean Bemis Head of Alliance Management @ Vividion Therapeutics
Head of Alliance Management
2017-10-01
Phil Baran Founder @ Vividion Therapeutics
Founder
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series C - Vividion Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Series C - Vividion Therapeutics
Logos Capital
Logos Capital investment in Series C - Vividion Therapeutics
SoftBank Vision Fund
SoftBank Vision Fund investment in Series C - Vividion Therapeutics
Boxer Capital
Boxer Capital investment in Series C - Vividion Therapeutics
Acuta Capital Partners
Acuta Capital Partners investment in Series C - Vividion Therapeutics
T. Rowe Price
T. Rowe Price investment in Series C - Vividion Therapeutics
Surveyor Capital
Surveyor Capital investment in Series C - Vividion Therapeutics
Nextech Invest
Nextech Invest investment in Series C - Vividion Therapeutics
Driehaus Capital Management
Driehaus Capital Management investment in Series C - Vividion Therapeutics
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-10-12 | Tavros Therapeutics | Vividion Therapeutics investment in Corporate Round - Tavros Therapeutics | 17.5 M USD |
Key Employee Changes
Official Site Inspections
http://www.vividion.com Semrush global rank: 660.5 K Semrush visits lastest month: 47.6 K
- Host name: 129.181.211.130.bc.googleusercontent.com
- IP address: 130.211.181.129
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Vividion Therapeutics"
About Us - Vividion Therapeutics
Aleksandra Rizo, M.D., Ph.D., joined Vividion in 2022 as President and Head of Research and Development. In 2023 Dr. Rizo was promoted to President and Chief Executive Officer and …See details»
Home — Vividion Therapeutics
Apr 3, 2025 Vividion’s unique chemoproteomics platform allows us to identify and pursue novel strategies to target pathways that contribute to human disease. One of the most rewarding …See details»
Vividion Therapeutics - Crunchbase Company Profile
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for …See details»
Bayer AG Completes its Acquisition of Vividion …
Aug 19, 2021 To preserve its entrepreneurial culture as an essential pillar for nurturing successful innovation, Vividion will continue to operate as an independent organization on an arm’s length basis. Vividion will remain …See details»
Vividion Therapeutics to Expand with New Global Research and
SAN DIEGO – July 23, 2024 – Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, …See details»
VIVIDION THERAPEUTICS INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for VIVIDION THERAPEUTICS INC of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Org Chart Vividion Therapeutics - The Official Board
Organizational Chart of Vividion Therapeutics. Vividion Therapeutics www.vividion.com. has 24 executives - and belongs to Bayer +1 858 345 4690; Add an executive. Vividion Therapeutics …See details»
Vividion Therapeutics - VentureRadar
Vividion Therapeutics is transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally inaccessible targets. We are …See details»
Covalent binding – Vividion | Bayer Global
Nov 7, 2023 Vividion’s unique approach utilizes novel discovery technologies to unlock high value, previously unknown binding pockets in traditionally undruggable targets to generate first-in-class precision therapeutics in …See details»
Vividion Therapeutics - Funding, Financials, Valuation & Investors
Vividion Therapeutics has acquired Tavros Therapeutics on Jan 8, 2025. Unlock for free . Funding Rounds. Number of Funding Rounds 5. Total Funding Amount . Unlock for free . Vividion …See details»
Join Us - Vividion Therapeutics
The term undruggable – you hear it a lot in our world. And NRF2/KEAP1, for example, is a complex that has classically been fitted with that description. But at Vividion we think in terms of …See details»
Vividion Therapeutics - Contacts, Employees, Board Members, …
Organization. Vividion Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 8. Number of …See details»
Vividion Therapeutics - Craft
Vividion is a biotechnology company focused on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome-wide drug and target …See details»
Vividion Therapeutics to Expand with New Global Research and ...
Jul 23, 2024 Vividion Media: Laurie Sherman, phone +1 858.630.8246 Email: media@vividion.com Bayer Media: Lisa Hennig, phone +49 172 8693420 Email: …See details»
Vividion Therapeutics to Expand with New Global Research and
San Diego, USA, July 23, 2024 – Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, …See details»
Vividion Therapeutics - 2025 Company Profile - Tracxn
Apr 4, 2025 Vividion Therapeutics is an acquired company based in Oceanside (United States), founded in 2016 by Alan Ezekowitz. It operates as a Developing novel drugs based on a …See details»
Vividion Therapeutics Doses First Patient in Phase I Study of
Apr 3, 2025 San Diego, CA, USA, Berlin, Germany April 3, 2025 – Vividion Therapeutics, Inc. (Vividion) today announced that the first patient has been dosed in a Phase I clinical trial …See details»
Bayer Strengthens Drug Discovery Platform Through Acquisition of ...
Aug 5, 2021 To preserve its entrepreneurial culture as an essential pillar for nurturing successful innovation, Vividion will continue to operate as an independent organization on an arm’s …See details»
Vividion Therapeutics to Expand with New Global Research and ...
Jul 23, 2024 Vividion Therapeutics, Inc., a wholly owned and independently operated subsidiary of Bayer AG, is a clinical stage biopharmaceutical company utilizing novel discovery …See details»
Bayer’s Vividion emerging as significant ... - Vividion Therapeutics
Aug 18, 2022 Vividion is already advancing multiple novel biology, first-in-class programs towards the clinic and has more than a dozen similar pipeline opportunities emerging in early …See details»